MAIA Biotechnology Inc (MAIA)
3.28
+0.13
(+4.13%)
USD |
NYAM |
May 03, 16:00
3.22
-0.06
(-1.83%)
After-Hours: 20:00
MAIA Biotechnology Price: 3.28 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 3.11 | 3.370 | 3.11 | 3.28 | 405254.0 |
May 02, 2024 | 3.19 | 3.248 | 3.09 | 3.15 | 237197.0 |
May 01, 2024 | 3.10 | 3.23 | 2.85 | 2.92 | 270132.0 |
Apr 30, 2024 | 3.21 | 3.59 | 2.79 | 2.93 | 670222.0 |
Apr 29, 2024 | 3.07 | 3.48 | 2.920 | 3.21 | 977345.0 |
Apr 26, 2024 | 2.70 | 3.00 | 2.651 | 2.94 | 450546.0 |
Apr 25, 2024 | 2.61 | 2.75 | 2.61 | 2.68 | 166189.0 |
Apr 24, 2024 | 2.45 | 2.73 | 2.39 | 2.69 | 397706.0 |
Apr 23, 2024 | 2.16 | 2.50 | 2.16 | 2.46 | 237396.0 |
Apr 22, 2024 | 2.13 | 2.32 | 2.08 | 2.26 | 111168.0 |
Apr 19, 2024 | 1.95 | 2.15 | 1.94 | 2.15 | 104725.0 |
Apr 18, 2024 | 1.98 | 2.03 | 1.92 | 1.96 | 67590.00 |
Apr 17, 2024 | 2.09 | 2.111 | 1.98 | 1.98 | 62070.00 |
Apr 16, 2024 | 2.02 | 2.094 | 1.851 | 2.06 | 111355.0 |
Apr 15, 2024 | 2.23 | 2.23 | 1.98 | 2.04 | 206571.0 |
Apr 12, 2024 | 2.47 | 2.47 | 2.19 | 2.205 | 178852.0 |
Apr 11, 2024 | 2.47 | 2.49 | 2.30 | 2.43 | 182845.0 |
Apr 10, 2024 | 2.57 | 2.57 | 2.36 | 2.46 | 190831.0 |
Apr 09, 2024 | 2.52 | 2.62 | 2.50 | 2.57 | 425202.0 |
Apr 08, 2024 | 2.35 | 2.52 | 2.31 | 2.49 | 256664.0 |
Apr 05, 2024 | 2.27 | 2.38 | 2.22 | 2.35 | 116849.0 |
Apr 04, 2024 | 2.34 | 2.40 | 2.20 | 2.20 | 127304.0 |
Apr 03, 2024 | 2.28 | 2.450 | 2.28 | 2.32 | 86417.00 |
Apr 02, 2024 | 2.47 | 2.65 | 2.26 | 2.35 | 298831.0 |
Apr 01, 2024 | 2.21 | 2.53 | 2.172 | 2.48 | 503195.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.83
Minimum
Dec 12 2023
7.80
Maximum
Aug 01 2022
2.727
Average
2.46
Median
Apr 28 2023
Price Benchmarks
Cyclacel Pharmaceuticals Inc | 2.00 |
Avid Bioservices Inc | 8.25 |
Oragenics Inc | 1.07 |
NeuBase Therapeutics Inc | 0.405 |
Viking Therapeutics Inc | 76.97 |
Price Related Metrics
Price to Book Value | 141.37 |
Earnings Yield | -45.73% |
Market Cap | 67.51M |